NCT03964688View on ClinicalTrials.gov

Effect of Vitamin C in Autologous Stem Cell Transplantations

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

December 10, 2019

Primary Completion Date

March 1, 2022

Study Completion Date

March 1, 2022

Conditions
Myeloma MultipleLymphoma
Interventions
DRUG

Vitamin C

vitamin C intravenous during hospitalization, after oral, total 6 weeks.

DRUG

Placebos

placebo intravenous during hospitalization, after oral, total 6 weeks

Trial Locations (1)

Unknown

MUMC+, Maastricht

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER

NCT03964688 - Effect of Vitamin C in Autologous Stem Cell Transplantations | Biotech Hunter | Biotech Hunter